Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Disparities in Cancer Specific and Overall Survival Outcomes in African Americans With Renal Cell Carcinoma: Analysis From the International Marker Consortium for Renal Cancer (INMARC).
Meagher MF, Patil D, Saito K, Javier-Desloges JF, Bradshaw AW, Patel SH, Cotta BH, Yasuda Y, Eldefrawy A, Ghali F, Nasseri R, Wan F, Fujii Y, Master V, Derweesh IH. Meagher MF, et al. Among authors: ghali f. Urology. 2022 May;163:164-176. doi: 10.1016/j.urology.2021.12.022. Epub 2022 Jan 5. Urology. 2022. PMID: 34995562
Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria.
Hamilton ZA, Capitanio U, Pruthi D, Ghali F, Larcher A, Patel DN, Eldefrawy A, Patel S, Cotta BH, Bradshaw AW, Meagher MF, Miller NS, Carenzi C, Wan F, Liss MA, McGregor T, Montorsi F, Derweesh IH. Hamilton ZA, et al. Among authors: ghali f. Urology. 2020 Apr;138:60-68. doi: 10.1016/j.urology.2019.11.036. Epub 2019 Dec 11. Urology. 2020. PMID: 31836465
Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma.
Roussel E, Campi R, Larcher A, Verbiest A, Antonelli A, Palumbo C, Derweesh I, Ghali F, Bradshaw A, Meagher MF, Heck M, Amiel T, Kriegmair MC, Rubio J, Musquera M, D'Anna M, Autorino R, Guruli G, Veccia A, Linares-Espinos E, Van Bruwaene S, Hevia V, Porpiglia F, Checcucci E, Minervini A, Mari A, Pavan N, Claps F, Marchioni M, Capitanio U, Beuselinck B, Mir MC, Albersen M; Young Academic Urologists Renal Cell Carcinoma Working Group. Roussel E, et al. Among authors: ghali f. Eur Urol Oncol. 2020 Aug;3(4):523-529. doi: 10.1016/j.euo.2020.04.006. Epub 2020 May 12. Eur Urol Oncol. 2020. PMID: 32414697 Free article.
A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group).
Wu Z, Chen Q, Djaladat H, Minervini A, Uzzo RG, Sundaram CP, Rha KH, Gonzalgo ML, Mehrazin R, Mazzone E, Marcus J, Danno A, Porter J, Asghar A, Ghali F, Guruli G, Douglawi A, Cacciamani G, Ghoreifi A, Simone G, Margulis V, Ferro M, Tellini R, Mari A, Srivastava A, Steward J, Al-Qathani A, Al-Mujalhem A, Bhattu AS, Mottrie A, Abdollah F, Eun DD, Derweesh I, Veccia A, Autorino R, Wang L. Wu Z, et al. Among authors: ghali f. Eur Urol Focus. 2022 Jan;8(1):173-181. doi: 10.1016/j.euf.2021.01.014. Epub 2021 Feb 3. Eur Urol Focus. 2022. PMID: 33549537
Corrigendum re "A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)" [Eur Urol Focus 2022;8:173-81].
Wu Z, Chen Q, Djaladat H, Minervini A, Uzzo RG, Sundaram C, Rha KH, Gonzalgo ML, Mehrazin R, Mazzone E, Marcus J, Danno A, Porter J, Asghar A, Ghali F, Guruli G, Douglawi A, Cacciamani G, Ghoreifi A, Simone G, Margulis V, Ferro M, Tellini R, Mari A, Srivastava A, Steward J, Al-Qathani A, Al-Mujalhem A, Satish Bhattu A, Mottrie A, Abdollah F, Eun DD, Derweesh I, Veccia A, Autorino R, Wang L. Wu Z, et al. Among authors: ghali f. Eur Urol Focus. 2022 Dec 30:S2405-4569(22)00294-2. doi: 10.1016/j.euf.2022.12.010. Online ahead of print. Eur Urol Focus. 2022. PMID: 36588010 No abstract available.
Robotic partial nephrectomy for clinical T2a renal mass is associated with improved trifecta outcome compared to open partial nephrectomy: a single surgeon comparative analysis.
Ghali F, Elbakry AA, Hamilton ZA, Yim K, Nasseri R, Patel S, Eldefrawy A, Ryan S, Bradshaw AW, Meagher M, Bree K, Reddy M, Lee HJ, Derweesh IH. Ghali F, et al. World J Urol. 2020 May;38(5):1113-1122. doi: 10.1007/s00345-019-02994-2. Epub 2019 Nov 8. World J Urol. 2020. PMID: 31701211
Comparison of renal functional outcomes of active surveillance and partial nephrectomy in the management of oncocytoma.
Meagher MF, Lane BR, Capitanio U, Mehrazin R, Bradshaw AW, Noyes S, Larcher A, Eldefrawy A, Ghali F, Patel D, Bruinius J, Dutt R, Keiner C, Miller N, Wan F, Montorsi F, Derweesh IH. Meagher MF, et al. Among authors: ghali f. World J Urol. 2021 Apr;39(4):1195-1201. doi: 10.1007/s00345-020-03299-5. Epub 2020 Jun 17. World J Urol. 2021. PMID: 32556559
Impact of positive surgical margins on survival after partial nephrectomy in localized kidney cancer: analysis of the National Cancer Database.
Ryan ST, Patel DN, Ghali F, Patel SH, Sarkar R, Yim K, Eldefrawy A, Cotta BH, Bradshaw AW, Meagher MF, Hamilton ZA, Murphy JD, Derweesh IH. Ryan ST, et al. Among authors: ghali f. Minerva Urol Nephrol. 2021 Apr;73(2):233-244. doi: 10.23736/S2724-6051.20.03728-5. Epub 2020 Aug 4. Minerva Urol Nephrol. 2021. PMID: 32748614 Free article.
81 results